Recent studies reveal troubling disparities in cardiovascular health outcomes among different racial and ethnic groups, particularly affecting Black women and veterans. Research shows that while pre-delivery cardiology care significantly lowers cardiovascular risks for white patients, it fails to produce similar outcomes for Black patients. Black women experience preeclampsia at rates 60% higher than white women, facing severe complications that lead to heightened risks of heart attack and stroke. Despite receiving specialized care, they encounter a stark contrast in health improvements.
In another striking analysis, Black veterans with obesity and type 2 diabetes were less likely to receive life-saving medications like semaglutide compared to their white counterparts. These medications can dramatically improve cardiovascular health, yet access remains alarmingly inequitable.
Compounding the issue, a study on heart failure patients found that adverse social determinants of health severely limit access to essential quadruple therapy, which could reduce mortality rates significantly. Individuals with Medicaid or no insurance were notably less likely to benefit from these treatments.
As discussions around diversity, equity, and inclusion continue, there is a growing recognition that the current approaches to address health equity may be inadequate. Researchers are calling for more comprehensive strategies to dismantle the barriers faced by minority populations in accessing equitable healthcare. The urgent need for systemic changes in medical practice and policy has never been clearer.
See “Cardiovascular health disparities persist in puzzling ways, studies find” (November 11, 2024)
